Pharmaceutical Pricing in a Globalized World: Crossing the income divide and ability to pay
OBJECTIVES To examine pharmaceutical pricing strategies not only through the lens of efficiency but equity as well, and propose analytic methods that support policymakers and executives in making pricing and reimbursement decisions. METHODS The paper takes a 3-dimensional approach (triangulation) in defining international pricing policy for pharmaceuticals using: cost-effectiveness analysis (CEA), willingness to pay analysis (WTP), and ability to pay analysis (ATP). It attempts to find a balance between various economic methods of which some focus on effectiveness while others are geared towards incorporating equity in the equation. RESULTS A model has been developed to assess the ATP of 120 countries based on a country’s score in the human development index (HDI) as defined and measured by the United Nations Development Program, and published annually in the United Nations Human Development Report. The non-linear index has been applied to a number of drugs in different therapeutic categories without disclosing brand names. Prices in affluent countries – and to an increasing extent in the fast-growing middleincome countries – could generate sufficient revenue to pay for the cost of innovation benefiting all parties, whereas prices in the lowest-income countries in principle need only cover their marginal cost. CONCLUSIONS Besides the standard cost-effectiveness analysis (CEA) and willingness to pay analysis (WTP), a third method should be used in conjunction that measures the ability to pay (ATP) with the HDI index as yardstick. We recommend that ATP becomes an additional practice in policy decision-making and in defining international pricing strategies for pharmaceuticals in order to provide sustainable access to medicines.
|Date of creation:||Sep 2012|
|Date of revision:|
|Contact details of provider:|| Postal: P.O. Box 1203, 6201 BE Maastricht|
Phone: +31 43 387 08 08
Fax: +31 43 387 08 00
Web page: http://research.msm.nl
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Daems, Rutger & Maes, Edith & Ramani, Shyama V., 2011. "Global Framework for Differential Pricing of Pharmaceuticals," MERIT Working Papers 054, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
When requesting a correction, please mention this item's handle: RePEc:msm:wpaper:2012/24. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Maud de By)
If references are entirely missing, you can add them using this form.